READ. SCROLL. LISTEN.

Unbiased headlines. Facts, not spin.

Unbiased Headlines is an independently owned news organization. We bring you the facts, not opinions, written fresh from 110+ named sources. Sources linked so you can verify it yourself.

← Back to headlines

Biotech CEO Urges Incoming Democratic Congress to Fund Fentanyl Vaccine as Biodefense Priority

Biotech CEO Urges Incoming Democratic Congress to Fund Fentanyl Vaccine as Biodefense Priority
ARMR Sciences CEO Collin Gage says America fights fentanyl "all wrong" by reversing overdoses instead of preventing them, and he wants the incoming Democratic Congress to build on Trump's weapon-of-mass-destruction designation. His vaccine is still an experimental product in a Phase 1/2 trial, and it will compete for attention with a long list of Democratic oversight targets.

ARMR Sciences CEO Collin Gage says the country is attacking the fentanyl crisis backward. In an interview with Fox News Digital, he argued that Washington spends its energy reversing overdoses after they start instead of blocking the drug before it reaches the brain.

His audience is the incoming Democratic-controlled Congress. Gage wants lawmakers to build on President Donald Trump's Dec. 15, 2025 executive order classifying illicit fentanyl as a "weapon of mass destruction." He called that designation "absolutely critical" to moving Washington toward a biodefense strategy.

The pitch

"If you look at the overdose crisis like any other health crisis, really as a disease, you'll know the best way to treat a crisis is by preventing it altogether," Gage said. He wants a "complete overhaul" of the treatment approach, one that has "historically led to tens of thousands of deaths, hundreds of thousands of deaths over the last several years."

Gage argues synthetic drugs are a distinct kind of biothreat. Sarin gas and anthrax can't easily be cooked up from a dark-web order, he said. Fentanyl, carfentanil, nitazenes and medetomidine can, because they are pharmaceutical-based agents. He said the damage in the United States is now starting to spread globally.

He also urged lawmakers to treat the issue as a "red, white and blue" priority rather than a partisan one. Fentanyl, he said, "does not discriminate" by race or socioeconomic status.

What exists so far

ARMR Sciences is currently running a Phase 1/2 clinical trial of its experimental fentanyl vaccine. The trial is evaluating safety and measuring how effectively the product keeps synthetic threats from reaching the brain.

The company describes the product as a preventative bloodstream countermeasure designed for battlefield bioterror threats. The first target is the military. "We want our first responders to be as effective as they possibly can in the field," Gage said.

Expansion to high-risk civilians, such as college students, comes later. Gage said safety and transparency have to come first.

A Phase 1/2 trial is an early stage. It is a long way from an approved product, and nothing in Gage's pitch changes that.

A crowded agenda

The pitch lands in a Congress with a lot on its plate. Democrats are about to control both the House and the Senate, and CNN's political desk has laid out nine targets it sees as the most practical for oversight of the Trump administration. CNN's list includes the military's strikes on alleged drug-trafficking boats in the Caribbean, the demolition of the White House East Wing, Elon Musk's DOGE efforts, and the botched Lincoln Memorial Reflecting Pool project.

Voters have mixed feelings about that. A Pew Research Center poll this week found 67% of Americans are more worried that congressional Democrats will investigate "too much," while 31% worry they will not investigate "enough."

The boat strikes sit closest to the drug issue. The administration has said the strikes target drug traffickers who are "unlawful combatants." Democratic Sen. Tim Kaine of Virginia says he reviewed the available evidence and concluded the strikes likely illegally killed "individuals who are not involved in narcotrafficking." Some Republicans have also been uneasy, particularly after a second "double-tap" strike on an alleged drug boat was revealed.

So the fight over drug policy in the next Congress may be about more than vaccines. It will also be about how far the executive branch can go with force.

Enforcement problems closer to home

The federal drug-fighting apparatus has its own open questions. New Mexico officials have launched a criminal investigation into allegations involving the DEA's handling of separate fentanyl shipments. The allegations, as described in coverage of the matter, are that the agency allowed other shipments to reach the streets. They are allegations only, and the DEA has not been shown in the sources to have conceded them.

On the border-enforcement side, Mexican military forces captured FBI Ten Most Wanted fugitive Fausto Isidro Meza-Flores, known as "Chapo Isidro," in Guasave, Mexico, with U.S. help. A gun battle broke out during the operation.

What comes next

Gage's argument is that a vaccine could shift fentanyl from a problem of response to a problem of prevention. That claim rests on a trial still underway. Whether the new Democratic majority makes synthetic-drug biodefense a priority, or spends its first months on the oversight list instead, is not yet settled.

The marker to watch is the ARMR trial itself. Gage has said safety and transparency come before any move from military use to civilians.

Sources used for this briefing

4 links from 4 independent newsrooms (syndicated copies of the same report count once)

These are the sources it draws on, linked so you can verify.

left
CNNThe Democrats’ top 9 targets for investigations next Congress | CNN Politics
right
Fox NewsBiotech CEO says the US is fighting fentanyl ‘all wrong,’ urges new Democratic Congress to step up
unknown
Eagle Country OnlineNational News - Eagle Country 99.3
unknown
wrganews.comBiotech CEO says the US is fighting fentanyl ‘all wrong,’ urges new Democratic Congress to step up